MCID: ATS025
MIFTS: 31

Autosomal Dominant Progressive External Ophthalmoplegia malady

Categories: Genetic diseases, Metabolic diseases, Rare diseases, Eye diseases, Neuronal diseases, Muscle diseases

Aliases & Classifications for Autosomal Dominant Progressive External Ophthalmoplegia

About this section
Sources:
23GeneTests, 52Orphanet, 29ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Autosomal Dominant Progressive External Ophthalmoplegia:

Name: Autosomal Dominant Progressive External Ophthalmoplegia 23 52
 
Adpeo 52

Classifications:



External Ids:

Orphanet52 ORPHA254892
ICD10 via Orphanet29 H49.4

Summaries for Autosomal Dominant Progressive External Ophthalmoplegia

About this section
MalaCards based summary: Autosomal Dominant Progressive External Ophthalmoplegia, also known as adpeo, is related to prop1-related combined pituitary hormone deficiency and deafness, autosomal dominant 30. An important gene associated with Autosomal Dominant Progressive External Ophthalmoplegia is POLG (DNA Polymerase Gamma, Catalytic Subunit), and among its related pathways are Synthesis and interconversion of nucleotide di- and triphosphates and Gemcitabine, Pharmacokinetics/Pharmacodynamics Pathway. Related mouse phenotypes are muscle and cardiovascular system.

Related Diseases for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Diseases in the Total Internal Ophthalmoplegia family:

Progressive External Ophthalmoplegia, Autosomal Recessive 1 Progressive External Ophthalmoplegia, Autosomal Dominant 1
Chronic Progressive External Ophthalmoplegia autosomal dominant progressive external ophthalmoplegia

Diseases related to Autosomal Dominant Progressive External Ophthalmoplegia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 20)
idRelated DiseaseScoreTop Affiliating Genes
1prop1-related combined pituitary hormone deficiency10.3C10orf2, POLG
2deafness, autosomal dominant 3010.2C10orf2, POLG
3charcot-marie-tooth disease type 2t10.2POLG, RRM2B
4perrault syndrome 510.2C10orf2, SLC25A4
5hypogonadism10.2
6colorectal adenocarcinoma10.1C10orf2, POLG
7progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 210.1
8progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 610.1
9progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 310.1
10progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 410.1
11progressive external ophthalmoplegia, autosomal dominant 110.1
12mitochondrial recessive ataxia syndrome10.0C10orf2, POLG, POLG2
13hallucinogen abuse10.0C10orf2, POLG
14mucopolysaccharidosis10.0C10orf2, POLG, SLC25A4
15cranial pseudosarcomatous fasciitis9.9C10orf2, POLG, SLC25A4
16mental retardation with spastic paraplegia9.8C10orf2, POLG, RRM2B, SLC25A4
17multiple epiphyseal dysplasia with robin phenotype9.6C10orf2, TFAM
18mitochondrial neurogastrointestinal encephalopathy disease9.5C10orf2, OPA1, POLG, SLC25A4
19ulceration of vulva9.5C10orf2, POLG, POLG2, RRM2B, SLC25A4
20autosomal recessive myosclerosis myopathy6.3C10orf2, DNA2, OPA1, POLG, POLG2, POLRMT

Graphical network of diseases related to Autosomal Dominant Progressive External Ophthalmoplegia:



Diseases related to autosomal dominant progressive external ophthalmoplegia

Symptoms for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Drugs & Therapeutics for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Drugs for Autosomal Dominant Progressive External Ophthalmoplegia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CysteaminePhase 2, Phase 32660-23-16058
Synonyms:
(2-Mercaptoethyl)amine
(Mercaptoethyl)ammonium toluene-p-sulphonate
.beta.-Mercaptoethylamine
1-Amino-2-mercaptoethylamine
139720-70-0
156-57-0 (hydrochloride)
16904-32-8 (di-hydrochloride)
2-AMINO-ETHANETHIOL
2-AMINO-ethanethiol
2-Amino-1-ethanethiol
2-Aminoethanethiol
2-Aminoethyl mercaptan
2-Mercaptoethanamine
2-Mercaptoethylamine
2-Mercaptoethylamine, polymer-bound
27761-19-9 (tartrate (1:1))
2DFDA1F8-7010-4225-8280-AB1C4C43F546
30070_FLUKA
30070_SIGMA
3037-04-5
3037-04-5 (tosylate)
42954-15-4 (hydrobromide)
60-23-1
60-23-1 (Parent)
641022_ALDRICH
93965-19-6 (maleate (1:1))
A0648
AC1L1LPL
AC1Q54NL
AKOS003793343
Aminoethyl mercaptan
Becaptan
C-9500
C01678
C2H7NS
CASH
CCRIS 3083
CHEBI:17141
CHEMBL602
CID6058
CYSTEAMINE
Cisteamina
Cisteamina [Italian]
Cystavision
Cysteamide
Cysteamin
Cysteamine
Cysteamine (USAN)
Cysteamine [USAN:BAN]
Cysteamine bitartate
Cysteamine hydrochloride
Cysteaminium
Cysteinamine
D03634
DB00847
Decarboxycysteine
DivK1c_006750
 
EINECS 200-463-0
EINECS 221-235-7
Ethanethiolamine
HSDB 7353
KBio1_001694
KBio2_002235
KBio2_004803
KBio2_007371
KBioSS_002235
L 1573
L-1573
LS-65761
Lambraten
Lambratene
Lopac-M-6500
M9768_ALDRICH
M9768_SIGMA
MEA
MEA (mercaptan)
Mecramine
Mercamin
Mercamine
Mercaptamin
Mercaptamina
Mercaptamina [INN-Spanish]
Mercaptamine
Mercaptamine (INN)
Mercaptaminum
Mercaptaminum [INN-Latin]
Mercaptoethylamine
Merkamin
MolPort-001-662-635
NCGC00015691-01
NCGC00015691-04
NCGC00162236-01
NCI60_002000
NSC 647528
NSC647528
Riacon
STK315355
SpecPlus_000654
Spectrum_001755
Thioethanolamine
UNII-5UX2SD1KE2
WR 347
b-Aminoethanethiol
b-Aminoethylthiol
b-Mercaptoethylamine
beta-Aminoethanethiol
beta-Aminoethylthiol
beta-MEA
beta-Mercaptoethylamine
bmse000388
cysteamine bitartrate
nchembio.315-comp1
nchembio.316-comp1
╬▓-MEA
╬▓-aminoethylthiol

Interventional clinical trials:

idNameStatusNCT IDPhase
1Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial DiseaseEnrolling by invitationNCT02023866Phase 2, Phase 3
2A Long-Term Extension Study of RP103-MITO-001 to Assess RP103 in Children With Inherited Mitochondrial DiseaseEnrolling by invitationNCT02473445Phase 2

Search NIH Clinical Center for Autosomal Dominant Progressive External Ophthalmoplegia

Genetic Tests for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Genetic tests related to Autosomal Dominant Progressive External Ophthalmoplegia:

id Genetic test Affiliating Genes
1 Autosomal Dominant Progressive External Ophthalmoplegia23 POLG

Anatomical Context for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Animal Models for Autosomal Dominant Progressive External Ophthalmoplegia or affiliated genes

About this section

MGI Mouse Phenotypes related to Autosomal Dominant Progressive External Ophthalmoplegia:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.5OPA1, POLG, RRM2B, SLC25A4, TFAM
2MP:00053858.0C10orf2, OPA1, POLG, RRM2B, SLC25A4, TFAM
3MP:00053847.5C10orf2, DNA2, OPA1, POLG, POLG2, RRM2B
4MP:00107686.9C10orf2, DNA2, OPA1, POLG, POLG2, RRM1

Publications for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Articles related to Autosomal Dominant Progressive External Ophthalmoplegia:

(show all 22)
idTitleAuthorsYear
1
Twinkle mutations in two Chinese families with autosomal dominant progressive external ophthalmoplegia. (24091712)
2013
2
TWINKLE gene mutation: report of a French family with an autosomal dominant progressive external ophthalmoplegia and literature review. (20880070)
2011
3
SLC25A4 and C10ORF2 Mutations in Autosomal Dominant Progressive External Ophthalmoplegia. (21519523)
2011
4
Clinical phenotype of autosomal dominant progressive external ophthalmoplegia in a family with a novel mutation in the C10orf2 gene. (19705478)
2010
5
A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. (19664747)
2009
6
Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure. (19853444)
2009
7
Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stalling. (18971204)
2009
8
Differential phenotypes of active site and human autosomal dominant progressive external ophthalmoplegia mutations in Drosophila mitochondrial DNA helicase expressed in Schneider cells. (17272269)
2007
9
A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. (15792871)
2005
10
Two families with autosomal dominant progressive external ophthalmoplegia. (15258213)
2004
11
Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. (15258572)
2004
12
A novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia. (12921794)
2003
13
A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions. (12112115)
2002
14
A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. (10364542)
1999
15
Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions. (10408540)
1999
16
Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24. (10522883)
1999
17
Association in the same patient of autosomal dominant progressive external ophthalmoplegia with multiple mtDNA deletions and X-linked ichthyosis: clinical, biochemical, histological, submicroscopic and molecular genetic study. (9851061)
1998
18
Rhabdomyolysis in autosomal dominant progressive external ophthalmoplegia. (9443501)
1998
19
Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. (9153451)
1997
20
Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism. (8609926)
1996
21
Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. (8957011)
1996
22
Anticipation of autosomal dominant progressive external ophthalmoplegia with hypogonadism. (8941270)
1996

Variations for Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Expression for genes affiliated with Autosomal Dominant Progressive External Ophthalmoplegia

About this section
Search GEO for disease gene expression data for Autosomal Dominant Progressive External Ophthalmoplegia.

Pathways for genes affiliated with Autosomal Dominant Progressive External Ophthalmoplegia

About this section

GO Terms for genes affiliated with Autosomal Dominant Progressive External Ophthalmoplegia

About this section

Cellular components related to Autosomal Dominant Progressive External Ophthalmoplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ribonucleoside-diphosphate reductase complexGO:000597110.4RRM1, RRM2B
2gamma DNA polymerase complexGO:000576010.1DNA2, POLG
3mitochondrial matrixGO:00057598.6C10orf2, POLG2, POLRMT, TFAM
4mitochondrial nucleoidGO:00426458.0C10orf2, DNA2, POLG, POLG2, POLRMT, TFAM
5mitochondrionGO:00057396.4C10orf2, OPA1, POLG, POLG2, POLRMT, RRM2B

Biological processes related to Autosomal Dominant Progressive External Ophthalmoplegia according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1deoxyribonucleotide biosynthetic processGO:000926310.3RRM1, RRM2B
2mitochondrial genome maintenanceGO:000000210.1OPA1, SLC25A4
3adenine transportGO:001585310.0SLC25A4, SLC25A6
4nucleobase-containing small molecule interconversionGO:001594910.0RRM1, RRM2B
5DNA biosynthetic processGO:00718979.9POLG, POLG2
6DNA-dependent DNA replicationGO:00062619.6POLG, POLG2, TFAM
7transcription initiation from mitochondrial promoterGO:00063919.5POLRMT, TFAM
8transcription from mitochondrial promoterGO:00063909.1C10orf2, POLRMT, TFAM
9mitochondrial DNA replicationGO:00062649.0C10orf2, DNA2, POLG, RRM2B
10DNA replicationGO:00062609.0DNA2, POLG2, RRM1
11mitochondrion organizationGO:00070057.8C10orf2, OPA1, POLG2, POLRMT, TFAM

Molecular functions related to Autosomal Dominant Progressive External Ophthalmoplegia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptorGO:000474810.0RRM1, RRM2B
2DNA-directed DNA polymerase activityGO:00038879.9POLG, POLG2
3adenine transmembrane transporter activityGO:00152079.8SLC25A4, SLC25A6
45-3 DNA helicase activityGO:00431399.6C10orf2, DNA2
5DNA helicase activityGO:00036789.4C10orf2, DNA2

Sources for Autosomal Dominant Progressive External Ophthalmoplegia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet